Extreme Obesity — The Silent Epidemic Within the Obesity Epidemic That No One Is Talking About

BMI ≥60 kg/m2 is rising faster than any other form of obesity — and remains the least studied.

MBS Digest — Vol. 2, N.o 8 (Edición en Español)

Acceso y riesgo quirúrgico en cirugía bariátrica, evidencia comparativa de incretínicos, transparencia de la IA y un pipeline de GLP-1 en expansión.

MBS Digest Vol. 2, Issue 8: AI transparency with patients and more

This week: Bariatric access and operative risk, comparative incretin evidence, and a widening GLP-1 pipeline

MBS Digest — Vol. 2, N.o 7 (Edición en Español)

Longitud del asa en Y de Roux, nicotina tras el bypass, gobernanza de la IA y los datos de fase 3 de avexitide.

MBS Digest Vol. 2, N.o 6 — Edición en Español

Las redes sociales sustituyen al médico en la educación sobre GLP-1 — y MÁS NOTICIAS

Las últimas noticias e investigación en medicina metabólica, AQUÍ

Social Media Replaces MDs for GLP1 Ed and MORE NEWS

Get the latest news and research on Metabolic Medicine HERE

MBS Digest Vol. 2, Issue 4

Beyond BMI: A Better Lens on Obesity Risk and Bariatric Outcomes and more of the latest news in metabolic news

Metabolic Market News

Stay ahead of the news cycle

This Week’s Must-Read Intelligence for Metabolic Leaders

Clinical studies on SADI, policy shifts with meds, industry movers and market watch insights in your focused digest.

Ahoy! There could be danger ahead! New Drugs and New Policy from the Latest Meetings

The MBS Digest keeps you informed of the latest news so you can avoid any rocks on the way to treasure island